# PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

> **NCT04396873** · PHASE1 · RECRUITING · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 184 (estimated)

## Conditions studied

- Parkinson's Disease
- Dementia
- Alzheimer's Disease
- ALS
- Mild Cognitive Impairment

## Interventions

- **DRUG:** 11C-MC1
- **DRUG:** 11C-PS13
- **DRUG:** 18f-florbetaben

## Key facts

- **NCT ID:** NCT04396873
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-08-17
- **Primary completion:** 2029-04-11
- **Final completion:** 2030-10-03
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04396873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04396873, "PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT04396873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*